A Trial of Three- and Seven-days Insulin Infusions Set
NCT06532461
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DEVICE:
Mio Advanced infusions set
DRUG:
Novorapid
DEVICE:
Extended wear insulin infusion (EWIS)
DRUG:
Humalog
Sponsor
Steno Diabetes Center Copenhagen